Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in NBP — NovaBridge Biosciences

CIK 1037389 NEW YORK, NY
Back to NBP Full portfolio

Position in NBP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,478,540
+$808,407 QoQ
Shares Held
758,226
+178.3% QoQ
Ownership
0.656%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 49 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. NBP ranks #153 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in NBP

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,478,540 758,226
2026-03-31 $670,133 272,412
2025-09-30 $240,408 63,600
2025-06-30 $154,154 63,700
2025-03-31 $52,571 63,800
2024-12-31 $54,230 63,800
2024-09-30 $79,112 63,800
2024-06-30 $106,546 63,800
2024-03-31 $118,668 63,800
2023-12-31 $121,220 63,800
2023-09-30 $84,216 63,800
2023-06-30 $736,460 246,308
2023-03-31 $719,015 207,808
2022-12-31 $196,878 47,100
2022-09-30 $646,011 161,100
2022-03-31 $2,231,376 137,400
2021-12-31 $10,653,272 224,800
2021-09-30 $15,984,045 220,500
2021-06-30 $14,775,200 176,000
2021-03-31 $5,045,727 104,100
2020-12-31 $6,619,860 140,400
2020-09-30 $5,173,300 110,000
2020-06-30 $703,355 23,500